SHIFT Newsroom · GLOBAL
Study Examines Weight Regain After Stopping Semaglutide or Tirzepatide
A new analysis looks at how weight regain occurs after discontinuing semaglutide or tirzepatide, but more evidence is needed to understand the full implications.
A recent study published on Europe PMC investigates the weight regain trajectories after stopping semaglutide or tirzepatide. While the study provides insights into the patterns of weight regain, more research is necessary to fully understand the implications for individuals using these medications in the UK.
SHIFT’s take
For individuals in the UK considering or currently using semaglutide or tirzepatide for weight management, understanding the patterns of weight regain after stopping these medications is crucial for making informed decisions about their health.
Known facts
- A study published on Europe PMC examines weight regain trajectories after discontinuation of semaglutide or tirzepatide.